| RBCSFRAG
| S2000 Fragmentation Reagent
|
| BioVendor
|
|
|
|
| 262 €
|
| RBCSICR
| Sircol™ Isolation & Concentration Reagent
|
| BioVendor
|
|
|
|
| 305 €
|
| RBCB1015
| Blyscan™ sGAG Isolation & Concentration Pack
|
| BioVendor
|
|
|
|
| 340 €
|
| RBCB1010
| Blyscan™ sGAG Reference Standard (100 µg/ml)
|
| BioVendor
|
|
|
|
| 291 €
|
| RBCSWASH
| Sircol™ Acid-Salt Wash
|
| BioVendor
|
|
|
|
| 305 €
|
| RBCB1007
| Blyscan™ Dissociation Reagent
|
| BioVendor
|
|
|
|
| 502 €
|
| RBCS6000
| Sircol™ Insoluble Collagen Assay (Large Economy Kit)
|
| BioVendor
|
|
|
|
| 1.277 €
|
| RBCS2010
| S2000 Denatured Collagen Standard (1 mg/ml)
|
| BioVendor
|
|
|
|
| 291 €
|
| RBCS1000
| Sircol™ Soluble Collagen Assay, Bovine Collagen (Standard Kit Size)
|
| BioVendor
|
|
|
|
| 530 €
|
| RBCS2000
| Sircol™ Insoluble Collagen Assay, Bovine Collagen (Standard Kit Size)
|
| BioVendor
|
|
|
|
| 509 €
|
| RBCF2300
| Fastin™ Dye Reagent
|
| BioVendor
|
|
|
|
| 1.058 €
|
| RBCS1010
| Sircol™ Bovine Collagen Reference Standard (0.5 mg/ml)
|
| BioVendor
|
|
|
|
| 305 €
|
| RBCF2010
| Fastin™ Elastin Reference Standard (1 mg/ml)
|
| BioVendor
|
|
|
|
| 340 €
|
| RMS01
| Haptoglobin Phenotype MALDI MS
|
| BioVendor
|
|
|
|
| A consultar
|
| RBCF4000
| Fastin™ Elastin Assay (Large Economy Kit)
|
| BioVendor
|
|
|
|
| 1.544 €
|
| RBCS5000
| Sircol™ Soluble Collagen Assay (Large Economy Kit)
|
| BioVendor
|
|
|
|
| 1.354 €
|
| RBCS1011
| Sircol™ Rat Collagen Reference Standard (0.5 mg/ml)
|
| BioVendor
|
|
|
|
| 326 €
|
| RBCS4000
| Sircol™ Soluble plus Sircol™ Insoluble Collagen Combination Pack
|
| BioVendor
|
|
|
|
| 889 €
|
| RBCH2000
| Purple-Jelley Hyaluronan Assay (Economy Kit)
|
| BioVendor
|
|
|
|
| 1.417 €
|
| RBCH1000
| Purple-Jelley Hyaluronan Assay (Standard Kit)
|
| BioVendor
|
|
|
|
| 558 €
|
| RBCS1005
| Sircol™ Dye Reagent
|
| BioVendor
|
|
|
|
| 593 €
|
| RBCB1000
| Blyscan™ sGAG Assay (Standard Kit Size)
|
| BioVendor
|
|
|
|
| 551 €
|
| RBCS1111
| Sircol™ Soluble Collagen Assay, Rat Collagen (Standard Kit Size)
|
| BioVendor
|
|
|
|
| 551 €
|
| RBCB1005
| Blyscan™ Dye Reagent
|
| BioVendor
|
|
|
|
| 551 €
|
| RBCB1500
| Blyscan™ Dye & Dissociation Reagents
|
| BioVendor
|
|
|
|
| 558 €
|
| RBCB3000
| Blyscan™ sGAG Assay (Large Economy Size)
|
| BioVendor
|
|
|
|
| 1.396 €
|
| RBCS1500
| Sircol™ Dye & Dye Release Reagents
|
| BioVendor
|
|
|
|
| 622 €
|
| RBCF2000
| Fastin™ Elastin Assay (Standard Kit Size)
|
| BioVendor
|
|
|
|
| 593 €
|
| RBCS1007
| Sircol™ Dye Release Reagent
|
| BioVendor
|
|
|
|
| 319 €
|
| LugA150Sur-01
| 1. Lung adenocarcinoma (75 cases), tumor (1 core/dase) and matched normal adjacent tissue (1 core/case).
2. Survival information available. Being followed up for more than 5 years.
3. With IHC data of VEGF and survivin.
| 1.5mm
| USBiolab
|
|
|
|
| € 985,00
|
| Liv01-002
| 1. Liver carcinoma (80 cases), 2 cores/case. Normal adjacent tissue (10 cases), 2 cores/case. Other tumor tissue (20 cases), 1 core/case.
2. Pathology grade 1, 2, 3.
| 1.0mm
| USBiolab
|
|
|
|
| € 255,00
|
| Kid02-003
| 1. Kidney clear cell carcinoma (32 cases), 1 core/case.
2. Pathology grade 2-3, 3.
| 2.0mm
| USBiolab
|
|
|
|
| € 156,00
|
| Eso4-007
| 1. Esophagus squamous cell carcinoma (45 cases), 2 cores/case.
2. Pathology grade 1, 1-2, 2, 2-3, 3.
| 2.0mm
| USBiolab
|
|
|
|
| € 241,00
|
| Rau120Sur-01
| 1. Kidney pelivis carcinoma and ureter carcinoma, 120cases. Tumor, 1 core/case
2. Survival information available. Being followed up for 0.5-7 years.
| 1.5mm
| USBiolab
|
|
|
|
| € 840,00
|
| Rec02-002
| 1. Rectum adenocarcinoma (32 cases), 1 core/case.
2. Pathology grade 2.
| 2.0mm
| USBiolab
|
|
|
|
| € 156,00
|
| Eso03-003
| 1. Esophagus carcinoma (21 cases), containing squamous cell carcinoma (9 cases), adenocarcinoma (5 cases), small cell carcinoma ( 6 cases) and undifferentiated carcinoma (1 case). Esophagogastric junction carcinoma (8 cases). Gastric carcinoma (2 cases
| 2.0mm
| USBiolab
|
|
|
|
| € 241,00
|
| Bre01-003
| 1. Breast carcinoma (80 cases), 2 cores/case. Normal adjacent tissue (10 cases), 2 cores/case. Other carcinoma (20 cases), 1 core/case.
2. Pathology grade 1, 2, 3.
3. ER, PR information.
| 1.0mm
| USBiolab
|
|
|
|
| € 325,00
|
| DS075-01
| 1. Carcinoma of large intestine, 14 cases have primary tissue, normal adjacent tissue and metastasis tissue, 14 cases have primary tissue and metastasis tissue, 4 cases have metstasis tissue.
| 2.0mm
| USBiolab
|
|
|
|
| € 400,00
|
| Rec180Sur-05
| 1. Rectum adenocarcinoma (90 cases) with survival information, tumor ( 1 core/case) and matched normal adjacent tissue.
2. Clinical stage I-IV (Version 7.0).
3. Surgery date 2008.12?2009.12, visit date 2014.3. Being followed up for 4.3-5.3 years.
| 1.5mm
| USBiolab
|
|
|
|
| € 1.168,00
|
| Lug150PT-01
| 1. Non-small cell lung carcinoma (75 cases), containing adenocarcinoma (30 cases), squamous cell carcinoma (30 cases), bronchio alveolar carcinoma (5 cases), adenosquamous carcinoma (7 cases) and large cell carcinoma (3 cases).
2. Tumor (1 core/case) an
| 1.5mm
| USBiolab
|
|
|
|
| € 400,00
|
| Col180-01
| 1. Colon adenocarcinoma (90 cases), tumor and NAT.
2. 100% cases have TNM detail information. Clinical stage I-IV (Version7.0).
3. Pathology grade 1, 2, 3.
| 1.5mm
| USBiolab
|
|
|
|
| € 545,00
|
| MorgF090-01
| 1. Multiple organ (24 types) normal tissue array. 2-6 cases /organ, 1 core /case.
2. Thyroid, tongue, esophagus, stomach, duodenum, jejunum, ileum, appendix, colon, rectum, liver, pancreas, trachea, lung, myocardial, artery, skeletal muscle, skin, prost
| 2.0mm
| USBiolab
|
|
|
|
| € 503,00
|
| Stm02-001
| 1. Gastric adenocarcinoma (32 casee), 1 core/case.
2. Pathology grade 1, 1-2
| 2.0mm
| USBiolab
|
|
|
|
| € 156,00
|
| Col060CS-01
| 1. Early colon adenocarcinoma, 30 cases. Tumor (1 core/case) and matched normal adjacent tissue (1 core/case). Wih clinical stage information (Version 7.0).
| 1.5mm
| USBiolab
|
|
|
|
| € 283,00
|
| Pro180-02
| 1. Prostate carcinoma(97 cases), 78 cases have tumor (1 core/case) and normal adjacent tissue (1 core/case). 19 cases have tumor (1 core/case). 5 cases have normal tissue.
2. Pathology grade and Gleason grade available.
| 1.5mm
| USBiolab
|
|
|
|
| € 695,00
|
| Stm030PT-01
| Various gastric diseaases, 1 core/case:normal gastric mucosa, gastric ulcer, gastric polyps and gastric intraepithelial neoplasia, gastric carcinoma/normal adjacent tissue
| 2.0mm
| USBiolab
|
|
|
|
| € 219,00
|
| Col180Sur-07
| 1. Colon adenocarcinoma (90 cases) with survival information, tumor(1 core/case) and matched normal adjacent tissue (1 core/case).
2. Clinical stage I-IV (Version7.0).
3. Surgery date 2009.1-2009.10, visit date 2014.5. Being followed up for 4.6-5.3 yea
| 1.5mm
| USBiolab
|
|
|
|
| € 1.207,00
|
| Bre140Sur-02
| 1. Breast cancer 140 cases. 1 core/case.
2. Clinical Stage I, II, III (Version 6.0).
3. Surgery date 2004.8?2008.12, visit date 2014.7 . Being followed up for 5.6~10 years.
4. 140 cases overlaped with Bre150Sur-02
| 1.5mm
| USBiolab
|
|
|
|
| € 1.243,00
|
| Liv02-001
| 1. Hepatocellular carcinoma (32 cases), 1 core/case.
2. Pathology grade 1, 1-2.
| 2.0mm
| USBiolab
|
|
|
|
| € 156,00
|
| Bre060-01
| 1. Breast carcinoma (30 cases), mainly invasive ductal carcinoma.
2. Tumor (1 core/case) and matched normal adjacent tissue (1 core/case).
3. Clinical stage 0, I, II, III (Version 6.0).
4. 100% cases have TNM detail information.
5. Pathology grade 1,
| 2.0mm
| USBiolab
|
|
|
|
| € 255,00
|